Literature DB >> 24193441

[Recurrent post-traumatic osteitis of the leg: Patent Blue V® dye, Gentamicin-PMMA-Beads and double muscular flap].

J Lambert1, O Bath, P Etienne, A C Mondo.   

Abstract

The authors describe the case of a 31-year old man who had a recurrent post-traumatic osteitis of the left leg with two fistulae for more than one year. Many unsuccessful proceedures were tried: removal of the tibial nail with reaming and filling with Gentamicin-PMMA-beads, fascio-cutaneous flap and open cancellous bone graft. They emphasize the bacteriological and imaging examinations particularly MRI. They recommend high-pressure oxygen therapy for a few days before operation in the case of chronic infected tissues, the use of Patent Blue V® dye to display bone sequestra prominently, filling with Gentamicin-PMMA-beads, an effective cover, in this case, with an original double muscular flap and long-term antibiotics. The rapid normalization of the CRP (C Reactive Protein) is a good sign of healing and the authors think that MRI allows early detection of recurrence of infection and shows the good perfusion of the muscular flap.

Entities:  

Year:  1995        PMID: 24193441     DOI: 10.1007/BF02716528

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  4 in total

1.  [Treatment of compound fractures of the leg using pedicled or free muscle flaps and supplemental bone grafts].

Authors:  A C Masquelet; B Augereau; A Apoil; J Y Nordin
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1987

2.  Immediate reactions to patent blue dye.

Authors:  K Kalimo; H Saarni
Journal:  Contact Dermatitis       Date:  1981-05       Impact factor: 6.600

3.  [The use of sulphan blue dye during surgical procedures for bone infection].

Authors:  G Jenny; I Kempf; J H Jaeger; S Betar; G Gebauer
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  1977-09

4.  Problems in the management of type III (severe) open fractures: a new classification of type III open fractures.

Authors:  R B Gustilo; R M Mendoza; D N Williams
Journal:  J Trauma       Date:  1984-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.